A pharma industry group wants the FDA and Fox to pull an ad from Hims & Hers promoting the company's weight-loss treatments
Eli Lilly sold $4.9 billion worth of Zepbound in 2024
Novo Nordisk CEO Lars Fruergaard Jørgensen says the company would not be "immune" to potential tariffs
Novo Nordisk, the maker of Ozempic, projects that its sales growth will slow down in 2025
Paid subscriptions for Disney+ fell 1% from the previous quarter to 124.6 million subscribers
Major pharma companies like Pfizer, Merck, and Amgen have remained relatively silent on whether they expect to be impacted
The Commodity Futures Trading Commission formally requested that Robinhood pull the plug
Pfizer CEO Albert Bourla said there are several issues the company could "collaborate" on with Robert F. Kennedy Jr.
Disney reports its fiscal first-quarter earrings. Can the company maintain its momentum from last year?
Dozens of brands including Taco Bell, TurboTax, and Reese's have started to rollout teasers and even full commercials set to air during the Super Bowl
The Healthcare Distribution Alliance and the Association for Accessible Medicines warn that Trump's tariffs could impact American patients
The price has spiked 88% in the last 10 years — and more than 20,000% since the first Super Bowl
Novo Nordisk and Pfizer are scoring big with NFL ads, but the Super Bowl remains a tough play for the industry
Meta CEO Mark Zuckerberg outlined the company's strategic priorities for 2025 in an hour-long meeting with workers
Plus, a LinkedIn co-founder just launched an AI drug startup, and Big Pharma raised prices on over 800 drugs
Ozempic is one of the 15 drugs set to undergo the Medicare price negotiation process next
The consumer genetic testing company is considering various options, including a potential sale, as it seeks additional liquidity
Microsoft and OpenAI have launched a probe into whether individuals connected to DeepSeek accessed data from OpenAI without authorization
Ozempic was found to reduce the combined risk of major kidney complications by 24% in patients with type 2 diabetes and chronic kidney disease
Lawmakers across the country have confirmed that their state’s Medicaid payment systems have been shut off
Robert F. Kennedy Jr. indicated he would consider using executive authority to take patents from expensive drugs that were developed using taxpayer money
The telehealth company is turning to the Super Bowl to market its off-brand Ozempic
The median price increase for the drugs affected is 4%
Netflix is leveraging live events and its growing ad business to cement its position as the dominant streaming platform
